Reverse vs Anatomic Shoulder Replacement for Shoulder Osteoarthritis
(CERVASA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two types of shoulder surgery, Reverse Total Shoulder Arthroplasty (RTSA) and Total Shoulder Arthroplasty (TSA), for individuals with severe shoulder osteoarthritis. The researchers aim to determine which surgery provides better outcomes in function and quality of life, while also resulting in fewer complications within the first year post-surgery. Suitable candidates have experienced shoulder pain and disability for at least six months despite treatments such as medication and physiotherapy. As an unphased trial, this study allows patients to contribute to valuable research that could enhance future treatment options for shoulder osteoarthritis.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Reverse Total Shoulder Arthroplasty (RTSA) is generally well-tolerated by older adults with osteoarthritis. Studies have found that it can greatly improve shoulder movement and reduce pain. However, some patients may experience problems with the shoulder implant, such as loosening or infection.
For Total Shoulder Arthroplasty (TSA), evidence suggests it also improves shoulder function and relieves pain. It is considered effective for people with shoulder arthritis. While complications can occur, they are usually manageable.
Both procedures have been safely used in many patients. Although each has its own risks, they are generally considered safe for treating advanced shoulder osteoarthritis in older adults.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer new approaches to shoulder osteoarthritis. Reverse Total Shoulder Arthroplasty (RTSA) is unique because it reconfigures the shoulder's anatomy by switching the ball-and-socket positions. This allows for better stability and function, especially in cases where rotator cuff muscles are compromised. On the other hand, Total Shoulder Arthroplasty (TSA) aims to restore the shoulder's natural anatomy, which can help improve the joint's alignment and function. Both techniques utilize advanced imaging and software for precise surgical planning, offering promising improvements over traditional shoulder replacement methods.
What evidence suggests that this trial's treatments could be effective for shoulder osteoarthritis?
This trial will compare Reverse Total Shoulder Arthroplasty (RTSA) with Total Shoulder Arthroplasty (TSA) for treating shoulder osteoarthritis. Research has shown that RTSA can greatly improve shoulder movement and reduce pain, particularly for individuals aged 60 and older, offering relief similar to other shoulder replacement surgeries. TSA also reduces pain and enhances shoulder function and is often recommended for patients with healthy rotator cuffs. Both RTSA and TSA offer significant benefits, but their suitability may vary based on the patient's shoulder condition and age.12467
Are You a Good Fit for This Trial?
This trial is for people aged 65 and older with advanced shoulder osteoarthritis who haven't improved after 6 months of non-surgical treatments like painkillers, anti-inflammatory drugs, and physiotherapy. It's not suitable for those with significant muscle paralysis, major illnesses limiting life expectancy or surgical risk, active compensation claims, previous shoulder surgery on the affected side, infections, certain joint conditions or psychiatric issues affecting consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Baseline measurements of shoulder range of motion, strength, and quality of life questionnaires are collected
Treatment
Participants undergo either Total Shoulder Arthroplasty (TSA) or Reverse Total Shoulder Arthroplasty (RTSA)
Post-operative Evaluation
Post-operative evaluations at 6 weeks, 3, 6, and 12 months to assess shoulder function and quality of life
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Reverse Total Shoulder Arthroplasty (RTSA)
- Total Shoulder Arthroplasty (TSA)
Reverse Total Shoulder Arthroplasty (RTSA) is already approved in European Union, United States for the following indications:
- Rotator cuff tear arthropathy
- Severe irreparable rotator cuff tears
- Shoulder osteoarthritis with severe bone loss
- Proximal humerus fractures
- Chronic shoulder dislocations
- Tumors of the shoulder joint
- Rotator cuff tear arthropathy
- Severe irreparable rotator cuff tears
- Shoulder osteoarthritis with severe bone loss
- Proximal humerus fractures
- Chronic shoulder dislocations
- Failed anatomical total shoulder arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
University Hospital Foundation
Collaborator
Canadian Orthopaedic Foundation
Collaborator